BAX Baxter International Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BAX

Price (delayed)

$20.095

Market cap

$10.38B

P/E Ratio

N/A

Dividend/share

$0.2

EPS

-$2.14

Enterprise value

$18.05B

?
Relative Growth: Rel. Growth: 17
Relative Strength: Rel. Strength: 40
Relative Valuation: Rel. Valuation: 36
Relative Profitability: Rel. Profitability: 20

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
Baxter International's debt has decreased by 6% YoY
The revenue is up by 5% year-on-year
BAX's net income has dropped by 96% year-on-year and by 15% since the previous quarter
The EPS has plunged by 95% YoY and by 14% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.baxter.com
Peers: CAH BSX SYK BDX

Key stats

What are the main financial stats of BAX

BAX stock price

How has the Baxter International stock price performed over time
Intraday
2.21%
1 week
-1.78%
1 month
4.77%
1 year
-32.99%
YTD
5.15%
QTD
19.61%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$11.32B
Gross profit
$3.41B
Operating income
-$300M
Net income
-$1.1B
Gross margin
30.1%
Net margin
-9.7%
BAX's net income has dropped by 96% year-on-year and by 15% since the previous quarter
Baxter International's net margin has plunged by 87% YoY and by 14% from the previous quarter
The gross margin is down by 17% year-on-year
The gross profit has declined by 12% year-on-year

Price vs fundamentals

How does BAX's price correlate with its fundamentals

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
BAX P/E details
P/E
N/A
P/B
1.71
P/S
0.91
EV/EBIT
N/A
EV/EBITDA
30.8
EV/Sales
1.59
The EPS has plunged by 95% YoY and by 14% from the previous quarter
BAX's P/B is 46% below its 5-year quarterly average of 3.1
The company's equity fell by 15% YoY
BAX's P/S is 56% below its 5-year quarterly average of 2.0 and 11% below its last 4 quarters average of 1.0
The revenue is up by 5% year-on-year

Efficiency

How efficient is Baxter International business performance
The ROA has plunged by 145% YoY and by 17% from the previous quarter
The company's return on equity has shrunk by 116% YoY and by 19% QoQ
The ROIC has plunged by 56% YoY and by 19% from the previous quarter
The ROS has contracted by 21% YoY and by 17% from the previous quarter

Dividends

What is BAX's dividend history
Dividend details
DPS
$0.2
Dividend yield
1%
Payout ratio
N/A
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Baxter International financials performed over time
The total assets is 43% more than the total liabilities
The quick ratio is down by 22% since the previous quarter and by 11% year-on-year
The current ratio fell by 20% QoQ and by 8% YoY
Baxter International's debt is 60% more than its equity
The company's equity fell by 15% YoY
The debt to equity has increased by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.